Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 28% ± 11% | |
astrocyte | 8 studies | 29% ± 13% | |
oligodendrocyte precursor cell | 6 studies | 30% ± 12% | |
GABAergic neuron | 6 studies | 39% ± 20% | |
oligodendrocyte | 6 studies | 25% ± 8% | |
glutamatergic neuron | 5 studies | 49% ± 22% | |
interneuron | 5 studies | 37% ± 22% | |
microglial cell | 5 studies | 23% ± 5% | |
adipocyte | 5 studies | 19% ± 3% | |
epithelial cell | 4 studies | 28% ± 12% | |
macrophage | 4 studies | 22% ± 5% | |
granule cell | 3 studies | 19% ± 3% | |
neuron | 3 studies | 29% ± 11% | |
endothelial cell of lymphatic vessel | 3 studies | 20% ± 5% | |
transit amplifying cell | 3 studies | 28% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4820.62 | 1445 / 1445 | 100% | 30.86 | 183 / 183 |
breast | 100% | 4522.05 | 459 / 459 | 100% | 24.62 | 1117 / 1118 |
lung | 100% | 3966.57 | 578 / 578 | 100% | 20.93 | 1153 / 1155 |
prostate | 100% | 4784.65 | 245 / 245 | 100% | 30.49 | 501 / 502 |
bladder | 100% | 4421.86 | 21 / 21 | 100% | 18.37 | 502 / 504 |
uterus | 100% | 4569.72 | 170 / 170 | 100% | 21.75 | 457 / 459 |
brain | 100% | 4328.44 | 2630 / 2642 | 100% | 24.49 | 705 / 705 |
intestine | 100% | 5236.21 | 966 / 966 | 99% | 18.58 | 524 / 527 |
skin | 100% | 4341.64 | 1809 / 1809 | 99% | 30.38 | 469 / 472 |
stomach | 100% | 3803.20 | 359 / 359 | 99% | 21.34 | 284 / 286 |
thymus | 100% | 4851.53 | 653 / 653 | 99% | 17.89 | 600 / 605 |
kidney | 100% | 4079.91 | 89 / 89 | 99% | 14.29 | 888 / 901 |
ovary | 100% | 3441.29 | 180 / 180 | 98% | 19.35 | 423 / 430 |
pancreas | 99% | 2537.64 | 326 / 328 | 99% | 14.92 | 176 / 178 |
liver | 100% | 3226.51 | 226 / 226 | 96% | 14.60 | 391 / 406 |
adrenal gland | 100% | 4658.81 | 258 / 258 | 90% | 11.01 | 208 / 230 |
adipose | 100% | 4164.18 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4277.14 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.74 | 29 / 29 |
muscle | 100% | 6063.21 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4670.70 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.81 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.14 | 1 / 1 |
heart | 98% | 3508.40 | 845 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 17.78 | 78 / 80 |
peripheral blood | 76% | 2020.61 | 710 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007040 | Biological process | lysosome organization |
GO_0007584 | Biological process | response to nutrient |
GO_0006954 | Biological process | inflammatory response |
GO_0016242 | Biological process | negative regulation of macroautophagy |
GO_1990253 | Biological process | cellular response to leucine starvation |
GO_0070885 | Biological process | negative regulation of calcineurin-NFAT signaling cascade |
GO_0016236 | Biological process | macroautophagy |
GO_0035264 | Biological process | multicellular organism growth |
GO_0046889 | Biological process | positive regulation of lipid biosynthetic process |
GO_0009267 | Biological process | cellular response to starvation |
GO_0060048 | Biological process | cardiac muscle contraction |
GO_0010831 | Biological process | positive regulation of myotube differentiation |
GO_0061431 | Biological process | cellular response to methionine |
GO_0002296 | Biological process | T-helper 1 cell lineage commitment |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0051549 | Biological process | positive regulation of keratinocyte migration |
GO_0030163 | Biological process | protein catabolic process |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0006468 | Biological process | protein phosphorylation |
GO_0045792 | Biological process | negative regulation of cell size |
GO_0048511 | Biological process | rhythmic process |
GO_0031641 | Biological process | regulation of myelination |
GO_0050882 | Biological process | voluntary musculoskeletal movement |
GO_0030838 | Biological process | positive regulation of actin filament polymerization |
GO_0009408 | Biological process | response to heat |
GO_0043200 | Biological process | response to amino acid |
GO_0001558 | Biological process | regulation of cell growth |
GO_0031295 | Biological process | T cell costimulation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0031670 | Biological process | cellular response to nutrient |
GO_0090559 | Biological process | regulation of membrane permeability |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_1900034 | Biological process | regulation of cellular response to heat |
GO_0045670 | Biological process | regulation of osteoclast differentiation |
GO_0006207 | Biological process | 'de novo' pyrimidine nucleobase biosynthetic process |
GO_1905857 | Biological process | positive regulation of pentose-phosphate shunt |
GO_0007281 | Biological process | germ cell development |
GO_0071470 | Biological process | cellular response to osmotic stress |
GO_0019228 | Biological process | neuronal action potential |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0045727 | Biological process | positive regulation of translation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0045821 | Biological process | positive regulation of glycolytic process |
GO_0003007 | Biological process | heart morphogenesis |
GO_0038202 | Biological process | TORC1 signaling |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0051496 | Biological process | positive regulation of stress fiber assembly |
GO_0055013 | Biological process | cardiac muscle cell development |
GO_0051647 | Biological process | nucleus localization |
GO_0003179 | Biological process | heart valve morphogenesis |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0031648 | Biological process | protein destabilization |
GO_1904059 | Biological process | regulation of locomotor rhythm |
GO_1903691 | Biological process | positive regulation of wound healing, spreading of epidermal cells |
GO_1905672 | Biological process | negative regulation of lysosome organization |
GO_0048714 | Biological process | positive regulation of oligodendrocyte differentiation |
GO_2000785 | Biological process | regulation of autophagosome assembly |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_1904690 | Biological process | positive regulation of cytoplasmic translational initiation |
GO_1900181 | Biological process | negative regulation of protein localization to nucleus |
GO_0016310 | Biological process | phosphorylation |
GO_0048266 | Biological process | behavioral response to pain |
GO_0071233 | Biological process | cellular response to L-leucine |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0045948 | Biological process | positive regulation of translational initiation |
GO_0009791 | Biological process | post-embryonic development |
GO_0031529 | Biological process | ruffle organization |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0031929 | Biological process | TOR signaling |
GO_0006974 | Biological process | DNA damage response |
GO_0010592 | Biological process | positive regulation of lamellipodium assembly |
GO_0043276 | Biological process | anoikis |
GO_0033173 | Biological process | calcineurin-NFAT signaling cascade |
GO_0031667 | Biological process | response to nutrient levels |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0045945 | Biological process | positive regulation of transcription by RNA polymerase III |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0048709 | Biological process | oligodendrocyte differentiation |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
GO_0008361 | Biological process | regulation of cell size |
GO_0016241 | Biological process | regulation of macroautophagy |
GO_1901838 | Biological process | positive regulation of transcription of nucleolar large rRNA by RNA polymerase I |
GO_0032516 | Biological process | positive regulation of phosphoprotein phosphatase activity |
GO_0006112 | Biological process | energy reserve metabolic process |
GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0012505 | Cellular component | endomembrane system |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0031931 | Cellular component | TORC1 complex |
GO_0016605 | Cellular component | PML body |
GO_0005634 | Cellular component | nucleus |
GO_0031932 | Cellular component | TORC2 complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0016020 | Cellular component | membrane |
GO_0005764 | Cellular component | lysosome |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005829 | Cellular component | cytosol |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0043022 | Molecular function | ribosome binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0001006 | Molecular function | RNA polymerase III type 3 promoter sequence-specific DNA binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0001156 | Molecular function | TFIIIC-class transcription factor complex binding |
GO_0001002 | Molecular function | RNA polymerase III type 1 promoter sequence-specific DNA binding |
GO_0001003 | Molecular function | RNA polymerase III type 2 promoter sequence-specific DNA binding |
GO_0016301 | Molecular function | kinase activity |
GO_0051219 | Molecular function | phosphoprotein binding |
Gene name | MTOR |
Protein name | Mechanistic target of rapamycin kinase Serine/threonine-protein kinase mTOR (EC 2.7.11.1) Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1) |
Synonyms | FRAP2 FRAP1 FRAP RAFT1 RAPT1 |
Description | FUNCTION: Serine/threonine protein kinase which is a central regulator of cellular metabolism, growth and survival in response to hormones, growth factors, nutrients, energy and stress signals . MTOR directly or indirectly regulates the phosphorylation of at least 800 proteins . Functions as part of 2 structurally and functionally distinct signaling complexes mTORC1 and mTORC2 (mTOR complex 1 and 2) . In response to nutrients, growth factors or amino acids, mTORC1 is recruited to the lysosome membrane and promotes protein, lipid and nucleotide synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis . This includes phosphorylation of EIF4EBP1 and release of its inhibition toward the elongation initiation factor 4E (eiF4E) . Moreover, phosphorylates and activates RPS6KB1 and RPS6KB2 that promote protein synthesis by modulating the activity of their downstream targets including ribosomal protein S6, eukaryotic translation initiation factor EIF4B, and the inhibitor of translation initiation PDCD4 . Stimulates the pyrimidine biosynthesis pathway, both by acute regulation through RPS6KB1-mediated phosphorylation of the biosynthetic enzyme CAD, and delayed regulation, through transcriptional enhancement of the pentose phosphate pathway which produces 5-phosphoribosyl-1-pyrophosphate (PRPP), an allosteric activator of CAD at a later step in synthesis, this function is dependent on the mTORC1 complex . Regulates ribosome synthesis by activating RNA polymerase III-dependent transcription through phosphorylation and inhibition of MAF1 an RNA polymerase III-repressor . Activates dormant ribosomes by mediating phosphorylation of SERBP1, leading to SERBP1 inactivation and reactivation of translation . In parallel to protein synthesis, also regulates lipid synthesis through SREBF1/SREBP1 and LPIN1 (By similarity). To maintain energy homeostasis mTORC1 may also regulate mitochondrial biogenesis through regulation of PPARGC1A (By similarity). In the same time, mTORC1 inhibits catabolic pathways: negatively regulates autophagy through phosphorylation of ULK1 . Under nutrient sufficiency, phosphorylates ULK1 at 'Ser-758', disrupting the interaction with AMPK and preventing activation of ULK1 . Also prevents autophagy through phosphorylation of the autophagy inhibitor DAP . Also prevents autophagy by phosphorylating RUBCNL/Pacer under nutrient-rich conditions . Prevents autophagy by mediating phosphorylation of AMBRA1, thereby inhibiting AMBRA1 ability to mediate ubiquitination of ULK1 and interaction between AMBRA1 and PPP2CA . mTORC1 exerts a feedback control on upstream growth factor signaling that includes phosphorylation and activation of GRB10 a INSR-dependent signaling suppressor . Among other potential targets mTORC1 may phosphorylate CLIP1 and regulate microtubules . The mTORC1 complex is inhibited in response to starvation and amino acid depletion . The non-canonical mTORC1 complex, which acts independently of RHEB, specifically mediates phosphorylation of MiT/TFE factors MITF, TFEB and TFE3 in the presence of nutrients, promoting their cytosolic retention and inactivation . Upon starvation or lysosomal stress, inhibition of mTORC1 induces dephosphorylation and nuclear translocation of TFEB and TFE3, promoting their transcription factor activity . The mTORC1 complex regulates pyroptosis in macrophages by promoting GSDMD oligomerization . MTOR phosphorylates RPTOR which in turn inhibits mTORC1 (By similarity). As part of the mTORC2 complex MTOR may regulate other cellular processes including survival and organization of the cytoskeleton . mTORC2 plays a critical role in the phosphorylation at 'Ser-473' of AKT1, a pro-survival effector of phosphoinositide 3-kinase, facilitating its activation by PDK1 . mTORC2 may regulate the actin cytoskeleton, through phosphorylation of PRKCA, PXN and activation of the Rho-type guanine nucleotide exchange factors RHOA and RAC1A or RAC1B . mTORC2 also regulates the phosphorylation of SGK1 at 'Ser-422' . Regulates osteoclastogenesis by adjusting the expression of CEBPB isoforms (By similarity). Plays an important regulatory role in the circadian clock function; regulates period length and rhythm amplitude of the suprachiasmatic nucleus (SCN) and liver clocks (By similarity). . |
Accessions | A0A8V8TQN3 A0A8V8TR74 ENST00000703142.1 A0A8V8TQM6 A0A8V8TRG9 ENST00000703140.1 ENST00000703143.1 A0A8V8TQP2 ENST00000361445.9 A0A8V8TQ52 ENST00000703139.1 ENST00000703141.1 ENST00000703118.1 P42345 |